Seven Mile Advisory Allogene Therapeutics, Inc. Put Options Transaction History
Seven Mile Advisory
- $166 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ALLO
# of Institutions
169Shares Held
162MCall Options Held
146KPut Options Held
97.1K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$23.8 Million1.28% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$20.9 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA11.2MShares$14.2 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR11.1MShares$14 Million3.7% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y910.5MShares$13.3 Million0.5% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $183M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...